Zobrazeno 1 - 10
of 513
pro vyhledávání: '"Hitoshi, Yoshiji"'
Autor:
Takuya Matsuda, Kosuke Kaji, Norihisa Nishimura, Shohei Asada, Aritoshi Koizumi, Misako Tanaka, Nobuyuki Yorioka, Yuki Tsuji, Koh Kitagawa, Shinya Sato, Tadashi Namisaki, Takemi Akahane, Hitoshi Yoshiji
Publikováno v:
Heliyon, Vol 10, Iss 19, Pp e38647- (2024)
Cabozantinib, a multiple tyrosine kinase inhibitor targeting AXL, vascular endothelial growth factor receptor (VEGFR), and MET, is used clinically to treat certain cancers, including hepatocellular carcinoma. This study aimed to assess the impact of
Externí odkaz:
https://doaj.org/article/2ee467f25f214818a6645a7449178218
Autor:
Koh Kitagawa, Hiroyuki Masuda, Akira Mitoro, Fumimasa Tomooka, Shohei Asada, Norihisa Nishimura, Kosuke Kaji, Hitoshi Yoshiji
Publikováno v:
Clinical Endoscopy, Vol 57, Iss 2, Pp 270-273 (2024)
Externí odkaz:
https://doaj.org/article/695b3dad4a194c9db793a13c9963aba5
Autor:
Kazuya Okushin, Ryosuke Tateishi, Shinya Hirakawa, Hisateru Tachimori, Koji Uchino, Ryo Nakagomi, Tomoharu Yamada, Takuma Nakatsuka, Tatsuya Minami, Masaya Sato, Mitsuhiro Fujishiro, Kiyoshi Hasegawa, Yuichiro Eguchi, Tatsuya Kanto, Hitoshi Yoshiji, Namiki Izumi, Masatoshi Kudo, Kazuhiko Koike
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract The number of cancer cases diagnosed during the coronavirus disease 2019 (COVID-19) pandemic has decreased. This study investigated the impact of the pandemic on the clinical practice of hepatocellular carcinoma (HCC) using a novel nationwid
Externí odkaz:
https://doaj.org/article/faac6bf7b5d942c8a81978239c425eca
Autor:
Yoshihiro Kamada, Hideki Fujii, Yuichiro Suzuki, Koji Sawada, Miwa Tatsuta, Tatsuji Maeshiro, Hiroshi Tobita, Tsubasa Tsutsumi, Takemi Akahane, Chitomi Hasebe, Miwa Kawanaka, Takaomi Kessoku, Yuichiro Eguchi, Hayashi Syokita, Atsushi Nakajima, Tomoari Kamada, Hitoshi Yoshiji, Takumi Kawaguchi, Hiroshi Sakugawa, Asahiro Morishita, Tsutomu Masaki, Takumi Ohmura, Toshio Watanabe, Yoshioki Yoda, Nobuyuki Enomoto, Masafumi Ono, Kanako Fuyama, Kazufumi Okada, Naoki Nishimoto, Yoichi M. Ito, Hirokazu Takahashi, Yoshio Sumida
Publikováno v:
Gastro Hep Advances, Vol 3, Iss 8, Pp 1148-1156 (2024)
Background and Aims: The clinical characteristics and risk factors involved in the development of liver fibrosis in the subtypes of steatotic liver disease (SLD) remain unknown. We examined the clinical characteristics of SLD subtypes using a large J
Externí odkaz:
https://doaj.org/article/8fc46b5475d448f3bd4a95a12cbd8638
Autor:
Kosuke Kaji, Soichi Takeda, Satoshi Iwai, Norihisa Nishimura, Shinya Sato, Tadashi Namisaki, Takemi Akahane, Hitoshi Yoshiji
Publikováno v:
Antioxidants, Vol 13, Iss 11, p 1415 (2024)
Imeglimin promotes glucose-stimulated insulin secretion in the pancreas in a glucose-dependent manner and inhibits gluconeogenesis in the liver. Meanwhile, imeglimin can improve mitochondrial function in hepatocytes. We used a nondiabetic metabolic d
Externí odkaz:
https://doaj.org/article/48a37e66523c4f30926e3948e683d95d
Autor:
Koh Kitagawa, Masafumi Oyama, Shohei Asada, Shinya Sato, Tatsuya Nakatani, Naoki Nishimura, Yuka Mui, Jun‐ichi Hanatani, Maiko Takeda, Hitoshi Yoshiji
Publikováno v:
DEN Open, Vol 4, Iss 1, Pp n/a-n/a (2024)
Abstract A 73‐year‐old woman with a history of rheumatoid arthritis treated with methotrexate (MTX) for the last 10 years was referred to our hospital for a pancreatic tumor examination. Contrast‐enhanced abdominal computed tomography revealed
Externí odkaz:
https://doaj.org/article/c6b865ba8c3946b79510214ee4ca6399
Autor:
Fumimasa Tomooka, Kei Moriya, Takahiro Kubo, Akihiko Shibamoto, Jyunya Suzuki, Satoshi Iwai, Soichi Takeda, Yuki Fujimoto, Masahide Enomoto, Koji Murata, Yuki Tsuji, Yukihisa Fujinaga, Koh Kitagawa, Norihisa Nishimura, Hiroaki Takaya, Kosuke Kaji, Hideto Kawaratani, Tadashi Namisaki, Takemi Akahane, Akira Mitoro, Hitoshi Yoshiji
Publikováno v:
Portal Hypertension & Cirrhosis, Vol 2, Iss 3, Pp 109-114 (2023)
Abstract Aims No solid evidence‐based opinion was raised regarding predictors of the degree of ascites reduction with tolvaptan. This retrospective cohort study aimed to examine whether serum copeptin concentration is a useful predictor of this. Me
Externí odkaz:
https://doaj.org/article/e1be7311656c4aa28671333c10daed45
Autor:
Fumimasa Tomooka, Koh Kitagawa, Akira Mitoro, Yuki Motokawa, Masayoshi Takami, Shohei Asada, Norihisa Nishimura, Takahiro Ozutsumi, Yukihisa Fujinaga, Hitoshi Yoshiji
Publikováno v:
SAGE Open Medical Case Reports, Vol 11 (2023)
A male patient underwent gastrojejunal bypass surgery in 2017. In 2020, he was referred to our hospital for suspected obstructive jaundice. Subsequently, he was diagnosed with cholangiocarcinoma, and endoscopic retrograde cholangiopancreatography was
Externí odkaz:
https://doaj.org/article/b2f03c2fd8494281a3474db50de99f65
Autor:
Shohei Asada, Kosuke Kaji, Norihisa Nishimura, Aritoshi Koizumi, Takuya Matsuda, Misako Tanaka, Nobuyuki Yorioka, Shinya Sato, Koh Kitagawa, Tadashi Namisaki, Takemi Akahane, Hitoshi Yoshiji
Publikováno v:
Cells, Vol 13, Iss 6, p 538 (2024)
Background: Liver cirrhosis leads to portal hypertension (PH) with capillarization of liver sinusoidal endothelial cells (LSECs), although drug treatment options for PH are currently limited. Sodium glucose transporter 2 inhibitors, which are antidia
Externí odkaz:
https://doaj.org/article/ebdebf1a7d914f6589aff0bfa045e5f6
Publikováno v:
Clinical Case Reports, Vol 11, Iss 5, Pp n/a-n/a (2023)
Key Clinical Message Venous thrombosis is a rare occurrence following the administration of the COVID‐19 mRNA vaccine. The occurrence of superior mesenteric vein (SMV) is even more rare. SMV thrombosis should be considered as a differential diagnos
Externí odkaz:
https://doaj.org/article/10c1215a0426411ebaba6b688a19054c